Search Within

Leonard Philip James

  1. "Sara Subzwari"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Nursing (5)
  2. Department of Medicine (4)
  3. Solid Tumor Oncology Division (4)
  4. Thoracic Oncology (4)
  5. Body Imaging Service (3)
  6. Department of Pathology and Laboratory Medicine (3)

More Groups

People
  1. Lee Krug (5)
  2. Leslie Tyson (5)
  3. Sara Subzwari (5)
  4. Mark Kris (4)
  5. Andrew Brown (3)
  6. Michelle Ginsberg (3)

More People

Years
  1. 2011 (2)
  2. 2010 (1)
  3. 2009 (1)
  4. 2007 (1)
Publications
  1. Cancer Chemotherapy and Pharmacology (1)
  2. Journal of Clinical Oncology (1)
  3. Journal of Thoracic Oncology (1)
  4. Lung Cancer (1)
  5. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (1)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Elsevier Ireland Ltd. (1)
  5. Springer (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
    Journal Article

    Paik, P. K.; Rudin, C. M.; Pietanza, M. C.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; more...
    Lung Cancer (2011)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
    Journal Article

    Paik, P. K.; Rudin, C. M.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; Markus, S.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase I study of obatoclax mesylate (GX15-070MS), a Bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors
    Meeting Abstract

    Brown, A. B.; Rudin, C.; Rizvi, N.; Travis, W.; Takebe, N.; James, L. P.; Subzwari, S.; Tyson, L.; Markus, S.; Krug, L. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of the anitfolate pralatrexate given with vitamin B12 and folic acid supplementation in patients with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    James, L. P.; Azzoli, C. G.; Krug, L. M.; Miller, V.; Tripathi, P.; Subzwari, S.; Tyson, L. B.; Dunne, M.; Huntington, M. F.; Saunders, M. E.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save